5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.

5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.

Item
http://www.wikidata.org/entity/Q44925317
Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus).The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients.Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis.Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew.Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients.Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting.Brain Fos expression induced by the chemotherapy agent cisplatin in the rat is partially dependent on an intact abdominal vagus.Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting.Chemotherapy-Induced Pica in Rats Reduced by Electroacupuncture.Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat.Therapeutic and preventive antiemetic effect of aprepitant in Japanese patients with thoracic malignancies who truly need it.
P2860

5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.

Item
http://www.wikidata.org/entity/Q44925317
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
5-Hydroxyindoleacetic acid and ...... iving emetogenic chemotherapy.
@en
5-Hydroxyindoleacetic acid and ...... iving emetogenic chemotherapy.
@nl
type
label
5-Hydroxyindoleacetic acid and ...... iving emetogenic chemotherapy.
@en
5-Hydroxyindoleacetic acid and ...... iving emetogenic chemotherapy.
@nl
prefLabel
5-Hydroxyindoleacetic acid and ...... iving emetogenic chemotherapy.
@en
5-Hydroxyindoleacetic acid and ...... iving emetogenic chemotherapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
5-Hydroxyindoleacetic acid and ...... iving emetogenic chemotherapy.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921